EdgarLookup

CytoMed Therapeutics Ltd — 6-K Filings

33 6-K filings on record

This page lists all 6-K filings submitted to the SEC by CytoMed Therapeutics Ltd (GDTC), sorted by most recent first. Each row links to the full filing on EdgarLookup. CytoMed Therapeutics Ltd has filed 33 6-K documents with the SEC since 2021. To view all SEC filings by CytoMed Therapeutics Ltd, see the full filings list.

Overview All Filings Financials Insiders
All 144 20-F 3 424B4 424B5 6-K 6-K/A 8-A12B CERT CORRESP DRS DRS/A DRSLTR EFFECT F-1 F-1/A F-3 FWP S-8 SC 13D SC 13G SC 13G/A SCHEDULE 13D/A SCHEDULE 13G SCHEDULE 13G/A SEC STAFF LETTER UPLOAD
Form Description Accession Number Filed Period
6-K 6-K 0001493152-26-003920 Jan 28, 2026
6-K 6-K 0001493152-26-001950 Jan 13, 2026
6-K 6-K 0001493152-25-026530 Dec 8, 2025
6-K 6-K 0001493152-25-023989 Nov 18, 2025
6-K 6-K 0001493152-25-020993 Nov 6, 2025
6-K 6-K 0001493152-25-018869 Oct 22, 2025
6-K 6-K 0001493152-25-017923 Oct 14, 2025
6-K 6-K 0001493152-25-016599 Oct 2, 2025
6-K 6-K 0001493152-25-016169 Sep 30, 2025 Jun 30, 2025
6-K 6-K 0001641172-25-025761 Aug 28, 2025
6-K 6-K 0001641172-25-024695 Aug 19, 2025 Aug 18, 2025
6-K 6-K 0001641172-25-020369 Jul 21, 2025
6-K 6-K 0001641172-25-017783 Jul 3, 2025
6-K 6-K 0001641172-25-017696 Jul 3, 2025
6-K 6-K 0001641172-25-011164 May 16, 2025
6-K CURRENT REPORT OF FOREIGN ISSUER 0001641172-25-006460 Apr 28, 2025
6-K 0001493152-25-000375 Jan 6, 2025
6-K 0001493152-24-048899 Dec 5, 2024
6-K 0001493152-24-046929 Nov 20, 2024
6-K 0001493152-24-039643 Oct 7, 2024
6-K 0001493152-24-039293 Oct 3, 2024
6-K 0001493152-24-038680 Sep 30, 2024
6-K 0001493152-24-024464 Jun 20, 2024
6-K 0001493152-24-021281 May 24, 2024
6-K 0001493152-24-015796 Apr 24, 2024
6-K 0001493152-24-010173 Mar 18, 2024
6-K 0001493152-24-008640 Mar 4, 2024
6-K 0001493152-24-004055 Jan 29, 2024
6-K 0001493152-23-041779 Nov 17, 2023 Jun 30, 2023
6-K 0001493152-23-033542 Sep 25, 2023
6-K 0001493152-23-026165 Aug 1, 2023
6-K 0001493152-23-023506 Jul 6, 2023
6-K 0001493152-23-012811 Apr 18, 2023